Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $217,908 - $277,505
-1,947 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $39,473 - $61,744
426 Added 28.01%
1,947 $229,000
Q4 2019

Feb 13, 2020

SELL
$116.25 - $133.25 $33,015 - $37,843
-284 Reduced 15.73%
1,521 $201,000
Q3 2019

Nov 08, 2019

SELL
$112.57 - $128.43 $66,416 - $75,773
-590 Reduced 24.63%
1,805 $225,000
Q2 2019

Jul 29, 2019

BUY
$97.98 - $114.28 $18,616 - $21,713
190 Added 8.62%
2,395 $272,000
Q1 2019

May 13, 2019

BUY
$81.56 - $100.67 $179,839 - $221,977
2,205 New
2,205 $222,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Claraphi Advisory Network, LLC Portfolio

Follow Claraphi Advisory Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.